Skip to main content
CBGL logo

Cannabis Global, Inc. (CBGL) Stock Price & Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.00001 $0.00 (0.00%)
Vol: 75.0K|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Cannabis Global, Inc. (CBGL) trades at $0.00001. Cannabis Global, Inc. focuses on developing and commercializing technologies for delivering hemp extracts and cannabinoids. The company offers cannabis products and storage solutions, primarily serving cannabis retailers and distributors. Sector: Healthcare.

Price as of · Last analyzed: Mar 17, 2026
Cannabis Global, Inc. focuses on developing and commercializing technologies for delivering hemp extracts and cannabinoids. The company offers cannabis products and storage solutions, primarily serving cannabis retailers and distributors.

Analyst Coverage for CBGL: CBGL does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

Scored companies in the same industry:

  • SXTC · China SXT Pharmaceuticals, Inc. · 19 /100
  • UPC · Universe Pharmaceuticals Inc. · 32 /100
  • BFRI · Biofrontera Inc. · 25 /100

See all scored stocks →

Cannabis Global, Inc. (CBGL) Healthcare & Pipeline Overview

CEOEdward Manolos
Employees3
HeadquartersLos Angeles, US
IPO Year2008

Cannabis Global, Inc. operates in the specialty drug manufacturing sector, focusing on engineered technologies for cannabinoid delivery. The company provides cannabis flower, pre-rolls, edibles, and storage solutions, targeting retailers and distributors in the regulated hemp and cannabis industries, while facing competition in a rapidly evolving market.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 17, 2026

What Is the Investment Thesis for CBGL?

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

Cannabis Global, Inc. presents a speculative investment opportunity within the cannabis industry, characterized by high growth potential and significant regulatory uncertainty. With a market capitalization of $0.00B and a negative P/E ratio of -2.79, the company's financial performance reflects its early stage and ongoing investments. The company's focus on engineered technologies for cannabinoid delivery and its Comply Bag solution offer potential differentiation in a competitive market. However, the OTC market listing and limited financial disclosure introduce substantial risk. Key growth catalysts include expansion of product offerings and successful penetration of new geographic markets. Investors should carefully consider the company's limited operating history, reliance on the evolving regulatory landscape, and the competitive pressures within the cannabis industry.

Based on FMP financials and quantitative analysis

CBGL Key Highlights

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

Focus on engineered technologies for cannabinoid delivery, potentially offering differentiated products.

  • Offers Comply Bag, a solution for cannabis storage, transport, and tracking, addressing a compliance need.
  • Provides managerial services in the regulated hemp and cannabis industries, diversifying revenue streams.
  • Market capitalization of $0.00B indicates a micro-cap company with high growth potential and associated risks.
  • Negative P/E ratio of -2.79 reflects current unprofitability and ongoing investments in growth initiatives.

Who Are CBGL's Competitors?

CBGL is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
SXTC China SXT Pharmaceuticals, Inc. $2.65 +2.12% —
UPC Universe Pharmaceuticals Inc. $1.08 -20.59% 32 5-pillar
BFRI Biofrontera Inc. $0.53 -7.02% $7.87M —
QNTM Quantum BioPharma Ltd. $1.29 -9.15% $8.29M 30 5-pillar
AKAN Akanda Corp. $4.23 +23.32% $11.2M —
COSM COSM $2.81 -2.09% $14.1M —
SHPH Shuttle Pharmaceuticals Holdings, Inc. $3.49 -10.51% $16.6M 32 5-pillar
CPHI CPHI $0.44 -13.00% $18.9M —

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CBGL's Key Strengths?

Focus on engineered technologies for cannabinoid delivery.

  • Comply Bag solution addresses a specific compliance need.
  • Provides managerial services in the regulated hemp and cannabis industries.
  • Established presence in the California cannabis market.

What Are CBGL's Weaknesses?

Limited financial resources and profitability.

  • Small number of employees.
  • Dependence on the evolving regulatory landscape.
  • OTC market listing indicates higher risk and lower liquidity.

What Are the Key Risks for CBGL?

Financial-distress signal — its Altman Z-Score of -49.66 sits in the distress zone (elevated bankruptcy risk).

  • Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
  • Changes in cannabis regulations could negatively impact the company's operations and profitability.
  • Intense competition from larger and more established cannabis companies.
  • Limited financial resources and profitability constrain growth opportunities.
  • Dependence on the evolving regulatory landscape creates uncertainty.
  • OTC market listing indicates higher risk and lower liquidity.

What Threats Does CBGL Face?

  • Intense competition from larger cannabis companies.
  • Changing regulatory landscape and potential for increased regulation.
  • Fluctuations in cannabis prices and demand.
  • Potential for product recalls and liability claims.

What Are CBGL's Competitive Advantages?

  • Proprietary engineered technologies for cannabinoid delivery.
  • Comply Bag solution addresses a specific need for regulatory compliance in cannabis storage and transport.
  • Expertise in the regulated hemp and cannabis industries provides a competitive advantage in managerial services.

What Does CBGL Do?

Cannabis Global, Inc., originally incorporated in 2005 as MCTC Holdings, underwent a transformation in December 2019, rebranding to reflect its focus on the cannabis industry. Headquartered in Los Angeles, California, the company specializes in creating and commercializing engineered technologies designed to deliver hemp extracts and cannabinoids to the human body. Cannabis Global's product portfolio includes a range of cannabis flower products, such as packaged flower, pre-rolls, and edible products, which are distributed to cannabis retailers and distributors. Additionally, the company offers Comply Bag, a solution tailored for cannabis storage, transport, and tracking, addressing a critical need for compliance within the regulated industry. Beyond its product offerings, Cannabis Global provides managerial services, leveraging its expertise in the regulated hemp and cannabis sectors to assist other businesses. This multifaceted approach positions Cannabis Global as a participant in both the product and service segments of the cannabis market, aiming to capitalize on the increasing demand for innovative cannabis solutions and regulatory compliance support.

What Products and Services Does CBGL Offer?

  • Creates and commercializes engineered technologies for delivering hemp extracts and cannabinoids.
  • Offers packaged cannabis flower products to retailers and distributors.
  • Provides pre-rolled cannabis products.
  • Manufactures and distributes cannabis edible products.
  • Offers Comply Bag, a solution for cannabis storage, transport, and tracking.
  • Provides managerial services in the regulated hemp and cannabis industries.

How Does CBGL Make Money?

  • Sells cannabis flower, pre-rolls, and edible products to cannabis retailers and distributors.
  • Generates revenue from the sale of Comply Bag, a cannabis storage and tracking solution.
  • Provides managerial services to businesses in the regulated hemp and cannabis industries.

What Industry Does CBGL Operate In?

Cannabis Global, Inc. operates within the rapidly evolving cannabis industry, which is characterized by increasing legalization, growing consumer demand, and intense competition. The market is driven by trends such as the increasing acceptance of cannabis for medical and recreational use, the development of innovative cannabis-based products, and the expansion of distribution channels. Cannabis Global competes with other companies in the cannabis product and service segments, including ATTBF (Aurora Cannabis Inc.), BIOIF (BioHarvest Sciences Inc.), HENC (Hemp, Inc.), INLB (InnoLabs, Inc.), and INSD (Inspiradigm, Inc.). The company's success depends on its ability to differentiate its products, navigate the complex regulatory landscape, and effectively compete for market share.

Who Are CBGL's Key Customers?

  • Cannabis retailers
  • Cannabis distributors
  • Businesses in the regulated hemp and cannabis industries seeking managerial services.
Model self-rating on this text: 69% (not a measure of the evidence) Updated: Mar 17, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● No usable price
  • ● No filing on record
  • ● No analyst coverage

Company Profile

Cannabis Global, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Los Angeles, United States.

ROE 3%

Key Financial Metrics

Return on equity for Cannabis Global, Inc. stands at 2.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -14.5%, showing how much profit it generates from its asset base. A current ratio of 0.05 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -195.3%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 2/9

Financial Health

Cannabis Global, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -49.66 places it in the distress zone, a signal of elevated financial risk.

Net selling

Insider Activity

12 transactions · 0 purchases, 12 sales, 0 other transactions · 1 identified insiders · most recent available transactions. Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

CBGL Latest News

No recent news available for CBGL.

CBGL Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for CBGL.

Price Targets

Wall Street price target analysis for CBGL.

CBGL MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for CBGL; grades run from A+ (80-100) to F (below 30).

Leadership: Edward Manolos

CEO

Edward Manolos serves as the CEO of Cannabis Global, Inc. His background includes experience in managing and developing businesses, with a focus on emerging industries. He has been involved in strategic planning, business development, and operational management. His leadership is focused on driving innovation and growth within the cannabis sector.

Track Record: Under Edward Manolos' leadership, Cannabis Global, Inc. has focused on developing and commercializing engineered technologies for cannabinoid delivery. Key milestones include the launch of the Comply Bag solution and the expansion of the company's product offerings. He is responsible for navigating the company through the evolving regulatory landscape and fostering strategic partnerships.

CBGL OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Cannabis Global, Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQB or OTCQX. Companies in this tier often have limited trading volume and may not be required to provide regular financial reports, increasing the risk for investors compared to companies listed on major exchanges like the NYSE or NASDAQ. These companies may also face greater scrutiny regarding their operations and financial stability.

  • OTC Tier: OTC Other
Liquidity: As an OTC stock, Cannabis Global, Inc. likely experiences limited trading volume and a wider bid-ask spread compared to stocks listed on major exchanges. This can make it difficult for investors to buy or sell shares quickly and at desired prices. The illiquidity of the stock increases the risk of price volatility and potential losses.
OTC Risk Factors:
  • Limited financial disclosure increases the risk of investing in Cannabis Global, Inc.
  • Low trading volume and wide bid-ask spread can make it difficult to buy or sell shares.
  • OTC Other tier status indicates a higher level of risk compared to stocks listed on major exchanges.
  • Dependence on the evolving regulatory landscape of the cannabis industry.
  • Intense competition from larger and more established cannabis companies.
Due Diligence Checklist:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the company's management team and their track record.
  • Assess the company's competitive position and market share.
  • Evaluate the company's regulatory compliance and risk management practices.
  • Analyze the company's cash flow and financial stability.
  • Check for any legal or regulatory issues involving the company.
  • Consult with a qualified financial advisor before investing.
Legitimacy Signals:
  • Focus on engineered technologies for cannabinoid delivery suggests innovation.
  • Comply Bag solution addresses a specific need for regulatory compliance.
  • Provides managerial services in the regulated hemp and cannabis industries, indicating expertise.
  • Operating history since 2005 provides some level of established presence.
  • Headquartered in Los Angeles, California, a major cannabis market.

Common Questions About CBGL (Healthcare)

What do analysts say about CBGL stock?

As of 2026-03-17, there is no readily available analyst coverage for Cannabis Global, Inc. (CBGL) due to its OTC listing and small market capitalization.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited financial information available due to OTC listing.
  • Analyst coverage is non-existent.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

Stock Deep Dives